Symbol="MRNS"
AssetType="Common Stock"
Name="Marinus Pharmaceuticals Inc"
Description="Marinus Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapies to treat rare seizure disorders. The company is headquartered in Radnor, Pennsylvania."
CIK="1267813"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="170 N RADNOR CHESTER RD, SUITE 250, RADNOR, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="397307000"
EBITDA="-126154000"
PERatio="None"
PEGRatio="0"
BookValue="1.632"
DividendPerShare="0"
DividendYield="0"
EPS="-0.64"
RevenuePerShareTTM="0.506"
ProfitMargin="-1.623"
OperatingMarginTTM="-5.95"
ReturnOnAssetsTTM="-0.439"
ReturnOnEquityTTM="-0.561"
RevenueTTM="21672000"
GrossProfitTTM="-55943000"
DilutedEPSTTM="-0.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.268"
AnalystTargetPrice="23.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.21"
PriceToBookRatio="2.654"
EVToRevenue="5.83"
EVToEBITDA="-37.38"
Beta="1.29"
num_52WeekHigh="11.15"
num_52WeekLow="3.465"
num_50DayMovingAverage="9.72"
num_200DayMovingAverage="7.07"
SharesOutstanding="50548000"
DividendDate="2020-09-23"
ExDividendDate="None"
symbol="MRNS"
open="7.46"
high="7.47"
low="6.47"
price="6.82"
volume="2229948.00"
latest_trading_day="2023-08-11"
previous_close="7.89"
change="-1.07"
change_percent="-13.5615%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="1"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="99"
Volume_recent_avg="775711"
Change_recent_avg="-0.01"
Delta_recent_avg="0.55"
Variance_recent_avg="0.28"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="99"
Aroon_momentum_negative="1"
image_negative_thumbnail_id_1="1116"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0149.jpeg"
image_negative_thumbnail_id_2="165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="996"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_positive_thumbnail_id_2="1006"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
